LSTA has been in the news 326% more than usual
Jan 07, 2026, 1:32 PM
136.34%
What does LSTA do
Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
LSTA has been in the news recently: LISATA THERAPEUTICS is not directly mentioned in the provided information, but related entities like BridGene Biosciences are advancing small-molecule therapeutics by appointing Nobel laureate Bruce A. Beutler to their Scientific Advisory Board. Additionally, Evogene Ltd. is collaborating with Unravel Biosciences to develop a therapy aimed at myelin restoration for multiple sclerosis patients.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.